Salmonella typhimurium Strains Expressing Human Arylamine JV-Acetyltransferases: Metabolism and Mutagenic Activation of Aromatic Amines

Cancer Research

Volumn 52, Issue 14, 1992, Pages 3961-3964

  Grant, Denis M ^b   Josephy, P David ^a   Lord, Heather L ^a   Morrison, Lesley D ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; 2 FLUORENYLAMINE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; BACTERIUM LYSATE; BENZIDINE;

AMES TEST; ARTICLE; CANCER RISK; CARCINOGENICITY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SPECIFICITY; HUMAN; METABOLIC ACTIVATION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ARYLAMINE N-ACETYLTRANSFERASE; BENZIDINES; BIOTRANSFORMATION; FLUORENES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; ISOENZYMES; MUTAGENICITY TESTS; SALMONELLA TYPHIMURIUM; SUPPORT, NON-U.S. GOV'T;

EID: 0026695811     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Blum, M., Grant, D. M., McBride, O. W., Heim, M., and Meyer, U. A. Human arylamine Macetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol., 9: 193-203, 1990.
2. Grant, D. M., Blum, M., Beer, M., and Meyer, U. A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol., 39: 184-191, 1991.
3. Blum, M., Demierre, A., Grant, D. M., Heim, M., and Meyer, U. A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA, 88: 5237-5241, 1991.
4. Deguchi, T., Mashimo, M., and Suzuki, T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine B-acetyltransferase in human liver. J. Biol. Chem., 265: 12757-12760, 1990.
5. Grant, D. M., Morike, K., Eichelbaum, M., and Meyer, U. A. Acetylation pharmacogenetics: the slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. J. Clin. Invest., 85: 968-972, 1990.
6. Evans, D. A. P. N-Acetyltransferase. Pharmacol. Ther., 42: 157-239, 1989.
7. McCoy, E. C., Anders, M., and Rosenkranz, H. S. The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP6 to the mutagenic action of nitroarenes. Mutat. Res., 121: 17-23, 1983.
8. Josephy, P. D. Oxidative activation and mutagenicity of benzidine. Fed. Proc., 45: 2465-2470, 1986.
9. Einisto, P., Watanabe, M., Ishidate, M., Jr., and Nohmi, T. MuUgenicity of 30 chemicals in Salmonella typhimurium strains possessing different nitroreductase or O-acetyltransferase activities. Mutat. Res., 259:95-102, 1991.
10. Saito, K., Shinohara, A., Kamataki, T., and Kato, R. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys., 239: 286-295, 1985.
11. MacFerrin, K. D., Terranova, M. P., Schreiber, S. L., and Verdine, G. L. Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 1937-1941, 1990.
12. Dupret, J-M., and Grant, D. M. Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia colL J. Biol. Chem., 267: 7381-7385, 1992.
13. McCoy, E. C., Rosenkranz, H. S., and Mermelstein, R. Evidence for the existence of a family of bacterial nitroreductases capable of activating nitrated polycyclics to mutagens. Environ. Mutagen., 3:421-427, 1981.
14. Watanabe, M., Nohmi, T., and Ishidate, M., Jr. New tester strains of Salmonella typhimurium highly sensitive to mutagenic nitroarenes. Biochem. Biophys. Res. Commun., 147:974-979, 1987.
15. Josephy, P. D., Chiu, A. L. H., and Eling, T. E. Prostaglandin H synthase-dependent mutagenic activation of benzidine in a Salmonella typhimurium Ames tester strain possessing elevated N-acetyltransferase levels. Cancer Res., 49: 853-856, 1989.
16. Grant, D. M., Lottspeich, F., and Meyer, U. A. Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Lett., 244: 203-207, 1989.
17. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
18. Watanabe, M., Ishidate, M., Jr., and Nohmi, T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltrans-ferase levels. Mutat. Res., 234: 337-348, 1990.
19. DeFrance, B. F., Carter, M. H., Josephy, P. D., Bryant, D. W., and McCalla, D. R. Metabolism and mutagenesis of benzidine in Salmonella typhimurium strains TA98 and TA98/1,8-DNP6. Mutat. Res., 144: 159-163, 1985.
20. Josephy, P. D. New developments in the Ames assay: high-sensitivity detection of mutagenic arylamines. Bioessays, 11: 108-112, 1989.
21. Ohgaki, H., Takayama, S., and Sugimura, T. Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res., 259: 399-410, 1991.
22. Hall, M. Tissue distribution of DNA adducts in CDFl mice fed 2-amino-3-methylimidazo[4,5-/]quinoline (IQ) and 2-amino-3,4-dimethylimidazo(4,5-/]quinoline (MelQ). Carcinogenesis (Lond.), 11: 1005-1011, 1990.
23. Hein, D. W., Rustan, T. D., and Grant, D. M. Human liver polymorphic (NAT2) and monomorphic (NATl) N-acetyltransferase isozymes catalyze metabolic activation of N-hydroxyarylamine and N-hydroxy-N-acetyl-ary-lamine proximate carcinogens. FASEB J., 6: A1274, 1992.
24. Hein, D. W. Acetylator genotype and arylamine-induced carcinogenesis. Bio-chim. Biophys. Acta, 948: 37-66, 1988.